![]()
|
|
||||||||
J. Biol. Chem., Vol. 256, Issue 17, 8907-8914, 09, 1981
TJ Wheeler and PC Hinkle
The kinetic parameters of D-glucose transport in liposomes reconstituted
with the purified glucose transporter were determined. Net uptake and
efflux both had Km values of 0.7 to 1.2 mM and Vmax values of 1.6 mumol/mg
of protein/min. Equilibrium exchange had a Km of 35 mM and a Vmax of 50
mumol/mg of protein/min. By separating the liposomes from unreconstituted
protein using density centrifugation, the Vmax of exchange was increased to
86 mumol/mg of protein/min, about 3 times that of the erythrocyte membrane.
Trypsin, which inhibits erythrocyte glucose transport only from the
cytoplasmic side, inhibited reconstituted transport activity about 40% when
added externally. With internal treatment as well, the inhibition was about
80%. This suggests that the reconstituted transporter is oriented about
equally in both directions. Antibody prepared against the purified
transporter inhibits transport to a maximum of about 50%, also indicating a
scrambled orientation. External trypsin treatment decreased the Km for
uptake and increased the Km for efflux, consistent with asymmetric kinetic
parameters for the two faces of the transporter. However, the calculated Km
values are lower than those reported for erythrocytes. Phloretin and
diethylstilbestrol inhibit the reconstituted transporter. However, they
bind to liposomes, producing anomalous results under some experimental
conditions. When this binding is taken into account, phloretin inhibits
completely and symmetrically. The binding accounts for the apparent
asymmetric effects of phloretin reported by others. The inhibitory effects
of mercuric ions are consistent with action at two classes of binding
sites. Treatment with trypsin increases the sensitivity to Hg2+, indicating
that the more sensitive site is on the external face of the transporter.
Kinetic properties of the reconstituted glucose transporter from human erythrocytes
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. Katsuno, Y. Fujimori, Y. Takemura, M. Hiratochi, F. Itoh, Y. Komatsu, H. Fujikura, and M. Isaji Sergliflozin, a Novel Selective Inhibitor of Low-Affinity Sodium Glucose Cotransporter (SGLT2), Validates the Critical Role of SGLT2 in Renal Glucose Reabsorption and Modulates Plasma Glucose Level J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 323 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Orci, B Thorens, M Ravazzola, and H. Lodish Localization of the pancreatic beta cell glucose transporter to specific plasma membrane domains Science, July 21, 1989; 245(4915): 295 - 297. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |